59
In band
Moving averages
SMA 200$19.23-2.29%
Company profile
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$1.81B
P/E ratioNone
EPS$-1.61
Beta0.205
Dividend yield0.00%
52-week high$25.32
52-week low$14.68
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 79
VRTX
Vertex Pharmaceuticals Inc
RSI 67
CRSP
CRISPR Therapeutics AG
RSI 67
IOVA
Iovance Biotherapeutics Inc
RSI 72
MRNA
Moderna Inc
RSI 72
VKTX
Viking Therapeutics Inc
RSI 48
EDIT
Editas Medicine Inc
RSI 57
NVAX
Novavax Inc
RSI 63
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 59
RSI alerts for SRPT
Get an email the moment Sarepta Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 6:55 AM EDT